Otero Jose Manuel
SEC insider (Form 3/4/5 filer). CIK 0002024096. Chief Operating Officer at Lexeo Therapeutics, Inc. (LXEO). 17 reported Form 4/5 transactions since Sep 2024; latest on Sep 24, 2026. Located in NEW YORK, NY.
Companies Otero Jose Manuel has filed insider reports for
- Lexeo Therapeutics, Inc. (LXEO): Officer, Chief Operating Officer
Otero Jose Manuel
CIK: 0002024096
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Lexeo Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Sep 24, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirectStock Option (right to buy)
54.8K shares- - Sep 14, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirect2.1K shares at avg. $2.64$6K - Aug 18, 2026LXEO
Lexeo Therapeutics, Inc.
SaleDirect1.3K shares at avg. $4.96$6K - Jul 1, 2026LXEO
Lexeo Therapeutics, Inc.
SaleDirect4.7K shares at avg. $4.48$21K - Jun 29, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirect12.1K shares- - May 18, 2026LXEO
Lexeo Therapeutics, Inc.
SaleDirect1.3K shares at avg. $5.07$7K - Mar 13, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirect5.9K shares at avg. $2.64$16K - Feb 18, 2026LXEO
Lexeo Therapeutics, Inc.
SaleDirect3K shares at avg. $6.40$19K - Feb 4, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirect65K shares- - Nov 18, 2025LXEO
Lexeo Therapeutics, Inc.
SaleDirect721 shares at avg. $9.27$7K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 | LXEO Lexeo Therapeutics, Inc. | Award Stock Option (right to buy) | 54,750 | - | - | Direct |
| Sep 14, 2026 | LXEO Lexeo Therapeutics, Inc. | Award | 2,110 | $2.64 | $5,579 | Direct |
| Aug 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale | 1,304 | $4.96 | $6,464 | Direct |
| Jul 1, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale | 4,666 | $4.48 | $20,904 | Direct |
| Jun 29, 2026 | LXEO Lexeo Therapeutics, Inc. | Award | 12,060 | - | $0 | Direct |
| May 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale | 1,302 | $5.07 | $6,606 | Direct |
| Mar 13, 2026 | LXEO Lexeo Therapeutics, Inc. | Award | 5,930 | $2.64 | $15,679 | Direct |
| Feb 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale | 3,016 | $6.40 | $19,294 | Direct |
| Feb 4, 2026 | LXEO Lexeo Therapeutics, Inc. | Award | 65,000 | - | $0 | Direct |
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Sale | 721 | $9.27 | $6,684 | Direct |
1-10 of 17 transactions